UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

BMC biology, 2012-03, Vol.10 (1), p.29-29, Article 29

2012

Volltextzugriff (PDF)

Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma

Cancer letters, 2013-09, Vol.338 (1), p.47-56

2013

Volltextzugriff (PDF)

Tumor spheroid-based migration assays for evaluation of therapeutic agents

Methods in molecular biology (Clifton, N.J.), 2013, Vol.986, p.253

2013

Volltextzugriff (PDF)

Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Arthritis research & therapy, 2023-08, Vol.25 (1), p.1-150, Article 150

2023

Volltextzugriff (PDF)

Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-170, Article 170

2023

Volltextzugriff (PDF)

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002934

2023

Volltextzugriff (PDF)

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

Rheumatic & musculoskeletal diseases open, 2024-03, Vol.10 (1), p.e003977

2024

Volltextzugriff (PDF)

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

Rheumatology and therapy., 2023-04, Vol.10 (2), p.489-505

2023

Volltextzugriff (PDF)

3D cell culture systems modeling tumor growth determinants in cancer target discovery

Advanced drug delivery reviews, 2014-04, Vol.69-70, p.29-41

2014

Volltextzugriff (PDF)

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Leukemia, 2022-10, Vol.36 (10), p.2418-2429

2022

Volltextzugriff (PDF)

Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site

Cancer letters, 2007-08, Vol.254 (1), p.128-136

2007

Volltextzugriff (PDF)

44145 Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB152-AB152

2023

Volltextzugriff (PDF)

P176 Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Volltextzugriff (PDF)

An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody‐Based Therapeutics in Overcoming Chemoresistance

Biotechnology journal, 2020-05, Vol.15 (5), p.e1900439-n/a

2020

Volltextzugriff (PDF)

Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2024-06, Vol.76 (6), p.894-904

2024

Volltextzugriff (PDF)

LSD 1 ( KDM 1A)‐independent effects of the LSD 1 inhibitor SP 2509 in cancer cells

British journal of haematology, 2018-11, Vol.183 (3), p.494-497

2018

Volltextzugriff (PDF)

LSD1 (KDM1A)‐independent effects of the LSD1 inhibitor SP2509 in cancer cells

British journal of haematology, 2018-11, Vol.183 (3), p.494-497

2018

Volltextzugriff (PDF)

Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers

Frontiers in bioscience (Landmark. Print), 2013-01, Vol.18 (2), p.520-542

2013

Volltextzugriff (PDF)

Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays

Methods in molecular biology (Clifton, N.J.), 2013, Vol.986, p.227

2013

Volltextzugriff (PDF)

The tumour microenvironment and response to therapeutic agents in head and neck squamous carcinoma cells

Zimmermann, Miriam

2011

Volltextzugriff (PDF)

Die >Heiligkeit des Lebens< in der Medizin

Zeitschrift für evangelische Ethik, 1997-01, Vol.41, p.217

Zimmermann, Miriam

1997

Volltextzugriff (PDF)

Reply to the Letter to the Editor by G.G. Van den Eynden et al

Cancer letters, 2007-10, Vol.256 (2), p.283-284

2007

Volltextzugriff (PDF)

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

Hepatology (Baltimore, Md.), 2009-07, Vol.50 (1), p.261-274

2009

Volltextzugriff (PDF)

Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum

World psychiatry, 2022-02, Vol.21 (1), p.26-54

2022

Volltextzugriff (PDF)

The ABC exporter IrtAB imports and reduces mycobacterial siderophores

Nature (London), 2020-04, Vol.580 (7803), p.413-417

2020

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(150)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma

Tumor spheroid-based migration assays for evaluation of therapeutic agents

Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

3D cell culture systems modeling tumor growth determinants in cancer target discovery

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site

44145 Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies

P176 Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies

An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody‐Based Therapeutics in Overcoming Chemoresistance

Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis

LSD 1 ( KDM 1A)‐independent effects of the LSD 1 inhibitor SP 2509 in cancer cells

LSD1 (KDM1A)‐independent effects of the LSD1 inhibitor SP2509 in cancer cells

Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers

Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays

The tumour microenvironment and response to therapeutic agents in head and neck squamous carcinoma cells

Die >Heiligkeit des Lebens< in der Medizin

Reply to the Letter to the Editor by G.G. Van den Eynden et al

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum

The ABC exporter IrtAB imports and reduces mycobacterial siderophores

Suchergebnisse filtern